A Technicality Could Keep RSV Shots From Kids in Need
The Vaccines for Children program may not cover the RSV shot for babies because it’s not technically a vaccine.
The Vaccines for Children program may not cover the RSV shot for babies because it’s not technically a vaccine.
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, the tripledemic of RSV, COVID-19, and influenza continues throughout the holiday season.
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
During April 2020 to May 2021, many respiratory viruses circulated at lower-than-expected levels.
The US Food and Drug Administration has issued marketing denial orders to JUUL Labs, essentially pulling the plug on JUUL vaping products.
Complaints of brain fog, fatigue, joint pain, shortness of breath, cough, and palpitations are familiar symptoms of patients with long COVID.
COVID-19 research is expected to yield medical and scientific dividends for the treatment of influenza, cancer, cystic fibrosis, and other chronic diseases.
Single injection administered before RSV season protects from medically attended RSV-associated lower respiratory tract infection.
This review covers the role of mucus hypersecretion in the pathogenesis of colds and flu and treatment options for mucus hypersecretion.